Migration of breast epithelial cells on Laminin-5: Differential role of integrins in normal and transformed cell types

Breast Cancer Research and Treatment

Volumn 51, Issue 1, 1998, Pages 57-69

  Plopper, George E ^a,c   Domanico, Susan Z ^a   Cirulli, Vincenzo ^b   Kiosses, William B ^a   Quaranta, Vito ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEVADA   (United States)

Author keywords

Breast neoplasms; Extracellular matrix; Haptotaxis; Integrins; Laminins

Indexed keywords

ANTIBODY; INTEGRIN; KALININ; MONOCLONAL ANTIBODY; RECEPTOR; SCLEROPROTEIN;

ARTICLE; BREAST EPITHELIUM; CELL ADHESION; CELL MIGRATION; CELL STRAIN MCF 7; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLS, CULTURED; DNA PRIMERS; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTEGRINS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0031794915     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006086218174     Document Type: Article

References (56)

1. Hynes RO: Integrins: Versatility, modulation and signaling in cell adhesion. Cell 69: 11-25, 1992
2. Craig SW, Johnson RP: Assembly of focal adhesions: progress, paradigms, and portents. Curr Opin Cell Biol 8: 74-85, 1996
3. Schwartz MA, Schaller MA, Ginsberg MH: Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 11: 549-599, 1995
4. Lauffenburger DA, Horwitz AF: Cell migration: a physically integrated molecular process. [Review]. Cell 84: 359-369, 1996
5. Huttenlocher A, Sandborg RR, Horwitz AF: Adhesion in cell migration. [Review]. Curr Opin Cell Biol 7: 697-706, 1995
6. Magro G, Lanzafame S, Colombatti A: Immunohistochemical staining patterns of type VI collagen in the normal, hyperplastic, and neoplastic adult male breast. Pathologica 86: 142-145, 1994
7. Christensen L: The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. [Review]. APMIS Suppl 26: 1-39, 1992
8. Coopman P, Verhasselt B, Bracke M, De Bruyne G, Castronovo V, Sobel M, Foidart JM, Van Roy F, Marcel M: Arrest of MCF-7 cell migration by laminin in vitro: possible mechanisms. Clin Exp Metastasis 9: 469-484, 1991
9. D'Ardenne AJ, Richman PI, Horton MA, Mcaulay AE, Jordan S: Co-ordinate expression of the alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer. J Pathol 165: 213-220, 1991
10. Yoshida T, Ishihara A, Hirokawa Y, Kusakabe M, Sakakura T: Tenascin in breast cancer development - is epithelial tenascin a marker for poor prognosis? [Review]. Cancer Lett 90: 65-73, 1995
11. Jaskiewicz K, Chasen MR, Robson SC: Differential expression of extracellular matrix proteins and integrins in hepato-cellular carcinoma and chronic liver disease. Anticancer Res 13: 2229-2237, 1993
12. Shoji T, Kamiya T, Tsubura A, Hamada Y, Hatano T, Hioki K, Morii S: Tenascin staining positivity and the survival of patients with invasive breast carcinoma. J Surg Res 55: 295-297, 1993
13. Moch H, Torhorst J, Durmuller U, Feichter GE, Sauter G, Gudat F: Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer. Pathol Res Pract 189: 510-514, 1993
14. Narita T, Kawakami-Kimura N, Sato M, Matsuura N, Higashiyama S, Kannagi R: Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells. Oncology 53: 374-381, 1996
15. Gui GP, Wells CA, Yeomans P, Jordan SE, Vinson GP, Carpenter R: Integrin expression in breast cancer cytology: a novel predictor of axillary metastasis. Eur J Surg Oncol 22: 254-258, 1996
16. Tawil NJ, Gowri V, Djoneidi M, Nip J, Carbonetto S, Brodt P: Integrin alpha 3 beta 1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma. Int J Cancer 66: 703-710, 1996
17. Shaw LM, Chao C, Wewer UM, Mercurio AM: Function of the integrin alpha 6 beta 1 in metastatic breast carcinoma cells assessed by expression of a dominant-negative receptor. Cancer Res 56: 959-963, 1996
18. Maemura M, Akiyama SK, Woods VL Jr, Dickson RB: Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells. Clin Exp Metastasis 13: 223-235, 1995
19. Glukhova M, Koteliansky V, Sastre X, Thiery JP: Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 146: 706-716, 1995
20. Friedrichs K, Ruiz P, Franke F, Gille I, Terpe HJ, Imhof BA: High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 55: 901-906, 1995
21. Gui GP, Wells CA, Browne PD, Yeomans P, Jordan S, Puddefoot JR, Carpenter R: Integrin expression in primary breast cancer and its relation to axillary nodal status. Surgery 117: 102-108, 1995
22. Oda K, Itoh H, Utsunomiya H, Itoh J, Osamura RY, Tokuda Y, Kubota M: Bio-histochemical aspects of integrins (alpha 2 beta 1, alpha 6 beta 1) in invasive mammary carcinomas: an immunohistochemical study. Pathol Int 44: 435-441, 1994
23. Arihiro K, Inai K, Kurihara K, Takeda S, Khatun N, Kuroi K, Toge T: A role of VLA-6 laminin receptor in invasion of breast carcinoma. Acta Pathol Jpn 43: 662-669, 1993
24. Sager R, Anisowicz A, Neveu M, Liang P, Sotiropoulou G: Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. Faseb J 7: 964-970, 1993
25. Jones JL, Critchley DR, Walker RA: Alteration of stromal protein and integrin expression in breast - a marker of premalignant change. J Pathol 167: 399-406, 1992
26. Natali PG, Nicotra MR, Botti C, Mottolese M, Bigotti A, Segatto O: Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer. Br J Cancer 66: 318-322, 1992
27. Koukoulis GK, Virtanen I, Korhonen M, Laitinen L, Quaranta V, Gould VE: Immunohistochemical localization of integrins in the normal, hyperplastic and neoplastic breast: Correlation with their functions as receptor and cell adhesion molecules. Am J Pathol 139: 787-799, 1991
28. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CMR, Pauley RJ, Jones RF, Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086, 1990
29. Band V, Sager R: Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 86: 1249-1253, 1989
30. Gelmann EP, Thompson EW, Sommers CL: Invasive and metastatic properties of MCF-7 cells and rasH-transfected MCF-7 cell lines. Int J Cancer 50: 665-669, 1992
31. Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717-721, 1990
32. Zhang RD, Fidler IJ, Price JE: Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metatasis. Invasion Metastasis 11: 204-215, 1991
33. Riddelle KS, Green KJ, Jones JCR: Formation of hemides-mosomes in vitro by a transformed rat bladder cell lines. J Cell Biol 112: 159-168, 1991
34. Lehmann M, Rabenandrasana C, Tamura RN, Lissitzky JC, Quaranta V, Pinchon J, Marvaldi J: A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins αVβ3, αVβ5 and αVβ6. Cancer Res 54: 2102-2107, 1994
35. Plopper G, Falk-Marzillier J, Glaser S, Fitchmun M, Giannelli G, Romano T, Jones JCR, Quaranta V: Changes in expression in monoclonal antibody epitopes on laminin-5r induced by cell contact. J Cell Sci 109: 1965-1973, 1996
36. Gospodarowicz D: Preparation of extracellular matrices produced by cultured bovine corneal endothelial cells and PF-UR-9 endodermal cells: Their use in cell culture. In: Barnes DW, Sirbasku DA, Stao GH (eds) Methods for Preparation of Media, Supplements and Substrata. Alan R. Liss, Inc., New York, 1984, pp 275-293
37. Albrecht-Buehler G: The phagokinetic tracks of 3T3 cells. Cell 11: 395-404, 1977
38. Tamura RN, Cooper HM, Collo G, Quaranta V: Cell-type specific integrin variants with alternative α chain cytoplasmic domains. Proc Natl Acad Sci USA 88: 10183-10187, 1991
39. Takada Y, Murphy E, Pil P, Chen C, Ginsberg MH, Hemler ME: Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha 3 beta 1 (VLA-3), an integrin receptor for fibronectin laminin and collagen. J Cell Biol 115: 257-266, 1991
40. Quaranta V, Plopper GE: Integrins and laminins in tissue remodeling. Kidney Int 51: 1441-1446, 1997
41. Wayner EA, Carter WG, Piotrowicz RS, Kunicki TJ: The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: Preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 107: 1881-1891, 1989
42. Sonnenberg A, Janssen H, Hogervorst F, Calafat J, Hilgers J: A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem 262: 10376-10383, 1987
43. Carter WG, Wayner EA, Bouchard TS, Kaur P: The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 110: 1387-1404, 1990
44. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V: Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277: 225-228, 1997
45. Mullen P, Ritchie A, Langdon SP, Miller WR: Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines. Int J Cancer 67: 816-820, 1996
46. Noel A, Borcy V, Bracke M, Gilles C, Bernard J, Birembaut P, Mareel M, Foidart JM: Heterotransplantation of primary and established human tumour cells in nude mice. Anticancer Res 15: 1-7, 1995
47. Bao L, Matsumura Y, Baban D, Sun Y, Tarin D: Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells. Br J Cancer 70: 228-232, 1994
48. Mehta RR, Graves JM, Hart GD, Shilkaitis A, Das Gupta TK: Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res Treat 25: 65-71, 1993
49. Bae SN, Arand G, Azzam H, Pavasant P, Torri J, Frandsen TL, Thompson EW: Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 24: 241-255, 1993
50. Lelievre S, Weaver VM, Bissell MJ: Extracellular matrix signaling from the cellular membrane skeleton to the nuclear skeleton: a model ofgene regulation. [Review]. Recent Prog Horm Res 51: 417-432, 1996
51. Stahl S, Weitzman S, Jones JCR: The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. J Cell Sci 110: 55-63, 1997
52. Niessen CM, Hogervorst F, Jaspars LH, de Melker AA, Delwel GO, Kuikman I, Sonnenberg A: The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Exp Cell Res 211: 360-367, 1994
53. Anbazhagan R, Bartkova J, Stamp G, Pignatelli M, Gusterson B: Expression of integrin subunits in the human infant breast correlates with morphogenesis and differentiation. J Pathol 176: 227-232, 1995
54. Xia Y, Gil SG, Carter WG: Anchorage mediated by integrin alpha 6 beta 4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein. J Cell Biol 132: 727-740, 1996
55. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K: Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 55: 4132-4139, 1995
56. Pyke C, Romer J, Kallunki P, Lund LR, Ralfkiaer E, Dano K, Tryggvason K: The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 145: 782-791, 1994